share

Hdm2 E3 Ligase Inhibitor CAS NO 414905-09-2


Unit Price:

CAS No.:414905-09-2

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Hdm2 E3 Ligase Inhibitor CAS NO 414905-09-2 is a potent and selective small molecule compound designed to target and inhibit the Hdm2 E3 ubiquitin ligase, a key regulator of the p53 tumor suppressor pathway. This targeted inhibition is crucial for reactivating p53 function in cancer cells, making it a valuable tool for oncology research and therapeutic development. It is primarily used by pharmaceutical R&D teams, academic researchers, and biotechnology companies focused on cancer biology, drug discovery, and the development of novel anti-cancer agents.

Application

  • Oncology Research & Drug Discovery: A critical tool for studying the p53-MDM2/MDMX interaction and screening for novel cancer therapeutics.
  • Biochemical Assay Development: Used as a reference standard or active component in high-throughput screening (HTS) and enzymatic assays.
  • Mechanism of Action Studies: Enables researchers to investigate apoptosis induction, cell cycle arrest, and tumor suppression mechanisms in vitro and in vivo.
  • Preclinical Development: Serves as a lead compound or pharmacophore model for optimizing pharmacokinetics and efficacy in animal models.
  • Combination Therapy Research: Explored in studies evaluating synergistic effects with chemotherapy, radiotherapy, or other targeted agents.
  • Academic & Institutional Research: Supports fundamental research in molecular biology, protein degradation pathways, and cellular signaling.

Basic Information

Product Name Hdm2 E3 Ligase Inhibitor
CAS No. 414905-09-2
Molecular Formula C₂₀H₁₅ClF₃N₅O₂
Molecular Weight 449.81 g/mol
Synonyms Nutlin-3; Nutlin 3; Nutlin-3a; RG7112 (Hydrochloride salt precursor); cis-4,5-Bis-(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydro-1H-imidazole-3-oxide; MDM2 antagonist; HDM2 inhibitor; p53-MDM2 interaction inhibitor
EINECS Contact for details

Quality Control

Our Hdm2 E3 Ligase Inhibitor is manufactured under strict quality systems to ensure batch-to-batch consistency and reliability for critical research applications. Each lot undergoes comprehensive analytical testing, including HPLC for purity verification and structural confirmation via NMR and Mass Spectrometry. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with every shipment to support your regulatory and research documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a dry, moisture-free environment. The product is hygroscopic (moisture-sensitive); allow the vial to equilibrate to room temperature in a desiccator before opening to prevent condensation and hydrolysis.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Conforms to reference standard
Identification (MS) Conforms to structure
Purity (HPLC) ≥98.0%
Water Content (KF) ≤1.0%
Residual Solvents (GC) Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.